Skip to content
Riskpilot
← Back to search
Sign in
Get full access
SVEGAARDEN PHARMAINVEST AS
AS
Active
Org 932840642
Stasjonsvegen 9, 2634
Fåvang
Retail sale of pharmaceutical products
· NACE 4773
Est. 2024
6 employees
Watchlist
Share
Norway
/
Companies
/
Retail sale of pharmaceutical products
/
SVEGAARDEN PHARMAINVEST AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
2M
4M
6M
8M
7M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
NOK thousands
Item
2024
Revenue
6 956
Staff expenses
−1 513
EBITDA
124
Depreciation & amort.
−101
EBIT
22
Net financials
−129
Profit before tax
−106
Tax
−0
Net profit
−106
Balance sheet
NOK thousands
Item
2024
Total assets
3 903
Equity
−82
Long-term debt
2 057
Short-term debt
1 928
Total debt
3 985
Financial ratios
5-year trend
EBITDA margin
1.8%
This company
15.8%
Market median
-89% vs market
2024
2024
Equity ratio
-2.1%
This company
38.2%
Market median
-105% vs market
2024
2024
Return on equity
-10633900.0%
This company
18.4%
Market median
-57793035% vs market
2024
2024
Net profit margin
-1.5%
This company
8.1%
Market median
-119% vs market
2024
2024
Asset turnover
1.78×
This company
1.12×
Market median
+59% vs market
2024
2024
Debt / equity
48.53×
This company
0.62×
Market median
-7727% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
More on SVEGAARDEN PHARMAINVEST AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
